|
|
(2S)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-2-(3-amino-3-deoxy-alpha-d-gl ucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-d-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide
CAS number: 38859-32-4
ASK FOR QUOTATIONGroups: Pharmaceutical, All Chemicals Information: IUPAC Name: (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3 ,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(ami nomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxy butanamide CAS Number: 38859-32-4 Chemical Formula: C22H43N5O13 Synonyms: 108914-65-4, 110660-81-6, 110660-83-8, 111319-93-8, 1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3 ,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(ami nomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxy butanamide, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3 ,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S ,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydro xy-cyclohexyl]-2-hydroxy-butanamide, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3 ,5-dihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6 -(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyc lohexyl]-2-hydroxy-butyramide, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-gl ucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydro xycyclohexyl]-2-hydroxybutanamide, (2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-g lucopyranosyl)oxy]-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-3-h ydroxycyclohexyl}-2-hydroxybutanamide, (2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tri hydroxy-oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S,6R)-4-azanyl-3,5-dihydr oxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxy-cyclohexyl]-4-azanyl-2-hy droxy-butanamide, 37517-28-5, 38859-32-4, 39831-55-5 (DISULFATE), AB00513828, AIDS007651, AIDS-007651, AIDS208770, AIDS-208770, Amicacin, Amiglyde-V, amikacin, Amikacina [INN-Spanish], Amikacin Base, Amikacin Dihydrate, Amikacine [INN-French], Amikacin plus Tumor Necrosis Factor, AMIKACIN SULFATE, Amikacinum [INN-Latin], Amikacin [USAN:BAN:INN], Amikacin (USP/INN), Amikavet, Amikin (Disulfate), AMK, Antibiotic BB-K 8, ANTIBIOTIC BB-K8, Arikace, BB-K8, BB-K 8, BPBio1_000671, Briclin, BSPBio_000609, C06820, C22H43N5O13, CHEBI:2637, D02543, DB00479, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-ami no-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobu tyl)-2-deoxy-, (S)-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-am ino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-N(sup 1)-(4-amino-2-hydroxy -1-oxobutyl)-2-deoxy-, (S)-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-ami no-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1 -oxobutyl)-2-deoxy-, (S)-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-ami no-6-deoxy-alpha-D-glucopyranosyl-(1,4))-N(sup 1)-(4-amino-2-hydroxy-1 -oxobutyl)-2-deoxy-, (S)-, EINECS 253-538-5, HSDB 3583, Kaminax, LS-146896, Lukadin, Mikavir, NCGC00093350-02, NCGC00093350-03, Novamin, NSC177001, NSC 177001, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alp ha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy- L-streptamine, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alph a-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deox y-L-streptamine, O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-. alpha.-D-glucopyranosyl-(1->4)]-1-(4-amino-2-hydroxy-1-oxobutyl)-2-deo xy-D-streptamine, Pierami, Prestwick3_000395, STK039706 Product info: Amikacin sulfate [ chemically : D-Streptamine, O-3-amino-3-deoxy-alpha-D- glucopyranosyl- (1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))- N1-(4-amino-2-hydroxy-1- oxobutyl)- 2-deoxy-, (S)-sulfate (1:2) (salt)] is a semi-synthetic aminoglycoside antibiotic derived from kanamycin. Its spectrum is somewhat broader than that of other aminoglycosides, including Serratia and Acinetobacter species, as well as certain staphylococci and streptococci. It is the most effective agent against gram-negative bacilli that have some aminoglycoside resistance. It is used for the treatment of serious infections resistant to gentamicin and tobramycin (bone infections, respiratory tract infections, endocarditis, and septicemia). Aminoglycoside is any of a group of antibiotics derived from various species of Streptomyces or Micromonosporaceae, while some of which are produced synthetically. Aminoglycosides inhibit bacterial protein synthesis by binding with the 30S ribosomal subunit and in some cases the 50S subunit, causing miscoding and thus inhibiting initiation and elongation during protein synthesis. They include;
Leave some information and we will contact you ASAP about the quotation of this product!
|
|